Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TBTC Study 28: Evaluation of a Moxifloxacin-based, Isoniazid-sparing Regimen for Tuberculosis Treatment

NCT00144417 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.

NCT NCT00144417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00144417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TBTC Study 28: Evaluation of a Moxifloxacin-based, Isoniazid-sparing Regimen for Tuberculosis Treatment
Lead sponsor
Centers for Disease Control and Prevention
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2006
Completion date
December 31, 2007
Enrollment
433 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis